Modulation of transcription factor NF-κB by enantiomers of the nonsteroidal drug ibuprofen

British Journal of Pharmacology

Volumn 123, Issue 4, 1998, Pages 645-652

  Scheuren, Nicole ^a   Bang, Holger ^a   Münster, Tino ^a   Brune, Kay ^a   Pahl, Andreas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Electrophoretic mobility shift assay; Heat shock transcription factor; Immunofluorescence; NF B; Nuclear import experiments; Prostaglandin E2; R Ibuprofen; Transient transfection

Indexed keywords

IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS; CHEMISTRY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR GENETICS; STEREOISOMERISM; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL TRANSPORT; CELL NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IBUPROFEN; JURKAT CELLS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; STEREOISOMERISM;

EID: 0031990814     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701652     Document Type: Article

References (49)

1. ABRAMSON, S.B. & WEISSMANN, G. (1989). The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum., 32, 1 - 9.
2. ADAMS, A.E. & PRINGLE, J.R. (1991). Staining of actin with fluorochrome-conjugated phalloidin. Methods Enzymol., 194, 729 - 731.
3. ALLEN, K.N. (1995). Aspirin - now we can see it. Nat. Med., 1, 882 - 883.
4. BACHELERIE, F., ALCAMI, J., ARENZANA-SEISDEDOS, F. & VIRELIZIER,. J.L. (1991). HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature. 350, 709 - 712.
5. BAEUERLE, P.A. & BALTIMORE, D. (1988). Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell, 53, 211 - 217.
6. BAEUERLE, P.A. & HENKEL, T (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12, 141 - 179.
7. BEG, A.A. & BALDWIN, A.S., Jr. (1993). The 1 kappa B proteins: multifunctional regulators of Rel NF-kappa B transcription factors. Genes Dev., 7, 2064 - 2070.
8. BEG, A.A., FINCO, T.S., NANTERMET, P.V. & BALDWIN, A.S., Jr. (1993). Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell. Biol., 13, 3301 - 3310.
9. BLASCHKE, V., JUNGERMANN, K. & PUSCHEL, O.P. (1996). Exclusive expression of the Gs-linked prostaglandin E2 receptor subtype 4 mRNA in mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells. FEBS Lett., 394, 39 - 43.
10. BOMSZTYK, K., TOIVOLA, B., EMERY, D.W., ROONEY, J.W., DOWER, S.K., RACHIE, N.A. & SIBLEY, C.H. (1990). Role of cAMP in interleukin-1-induced kappa light chain gene expression in murine B cell line. J. Biol. Chem., 265, 9413 - 9417.
11. BONEBERG, E.M., ZOU, M.-H. & ULLRICH,V. (1996). Inhibition of cyclooxygenase-1 and -2 by R (-)- and S(+)-ibuprofen. J. Clin. Pharmacol., 36, 16S - 19S.
12. BROOKS, P.M. & DAY, R.O. (1991). Nonsteroidal antiinflammatory drugs - differences and similarities. N. Engl. J. Mad., 324, 1716 - 1725.
13. BRUNE, K., BECK, W.S., GEISSLINGER, G., MENZEL-SOGLOWEK, S., PESKAR, B.M. & PESKER, B.A. (1991). Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia, 47, 257 - 261.
14. CRABTREE, G.R. & CLIPSTONE, N.A. (1994). Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem., 63, 1045 - 1083.
15. DEGITZ, K., LIAN-JIE, L. & CAUGHMAN, S.W. (1991). Cloning and characterization of the 5′ - transcriptional regulatory region of the human intercellular adhesion molecule ł gene. J. Biol. Chem., 266, 14024 - 14030.
16. FEUILLARD, J., GOUY, H., BISMUTH, G., LEE, L.M., DEBRE, P. & KORNER, M. (1991). NF-kappa B activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of proteinkinase A. protein kinase C. and Ca(2+)-regulated kinases. Cytokine. 3, 257 - 265.
17. FINCO, T.S., BEG, A.A. & BALDWIN, A.S., Jr. (1994). Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. U.S.A.. 91, 11884 - 11888.
18. FRANTZ, B. & O'NEILL, E.A. (1995). The effect of sodium salicylate and aspirin on NF-kappa B. Science. 270, 2017 - 2019.
19. GEISSLINGER, G., FERREIRA, S.H., MENZEL, S., SCHLOTT, D & BRUNE, K. (1994). Antinociceptive actions of R (-)-flurbiprofen - a non-cyclooxygenase inhibiting 2-aryl-propionic acid - in rats. Life Sci., 54, L173 - 177.
20. GHOSH, S. & BALTIMORE, D. (1990). Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature, 344, 678 - 682.
21. GRILLI, M., CHIU, J.S. & LEONARDO, M.J. (1993). NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol., 143, 1 - 62.
22. GRILLI, M., PIZZI, M., MEMO, M. & SPANO, P. (1996). Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science, 274, 1383 - 1385.
23. 2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. J. Biol. Chem., 272, 8546 - 8550.
24. HAROOTUNIAN, A.T., ADAMS, S.R., WEN, W., MEINKOTH, J.L., TAYLOR, S.S. & TSIEN. R.Y. (1993). Movement of the free catalytic subunit of cAMP-dependent protein kinase into and out of the nucleus can be explained by diffusion. Mol. Biol. Cell. 4, 993 - 1002.
25. JURIVICH, D.A., SISTONEN, L., KROES, R.A. & MORIMOTO, R.I. (1992). Effect of sodium salicylate on the human heat shock response. Science. 255, 1243 - 1245.
26. KOPP, E. & GHOSH, S. (1994). Inhibition of NF-kappa B by sodium salicylate and aspirin. Science, 265, 956 - 959.
27. KUMAR, S., RABSON, A.B. & GELINAS, C. (1992). The RxxRxRxxC motif conserved in all Rel kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol., 12, 3094 - 3106.
28. LEE, B.S., CHEN, J., ANGELIDIS, C., JURIVICH, D.A. & MORIMOTO, R.I. (1995). Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stressinduced cellular damage. Proc. Natl. Acad. Sci. U.S.A., 92, 7207 - 7211.
29. LIOU, H.C. & BALTIMORE, D. (1993). Regulation of the NF-kappa B rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell. Biol., 5, 477 - 487.
30. MAHON, T.M. & O'NEILL, L.A. (1995). Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. J. Biol. Chem., 270, 28557 - 28564.
31. MCCORMACK, K. & BRUNE, K. (1991). Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs. 41, 533 - 547.
32. MEADE, E.A., SMITH, W.L. & DeWITT, D.L. (1993). Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J. Biol. Chem., 268, 6610 - 6614.
33. MEICHLE, A., SCHUTZE, S., HENSEL, G., BRUNSING, D & KRONKE, M. (1990). Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor. J. Biol. Chem., 265, 8339 - 8343.
34. MIYAMOTO, S., CHIAO, P.J. & VERMA, L.M. (1994). Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol. Cell. Biol., 14, 3276 - 3282.
35. NEISH , A.S., WILLIAMS, J., PALMER, H.J., WHITLEY, M.Z. & COLLINS, T (1992). Functional analysis of the human vascular cell adhesion molecule 1 promotor. J. Exp. Med., 176, 1583 - 1593.
36. NEUPERT, W., BRUGGER, R., EUCHENHOFER, C., BRUNE, K. & GEISSLINGER, G. (1998). Effects of ibuprofen enantiomers and its coenzym A thioesters on human prostaglandin endoperoxide synthases. Br. J. Pharmacol., 122, 487 - 492.
37. PANTE, N. & AEBI, U. (1996). Toward the molecular dissection of protein import into nuclei. Curr. Opin. Cell. Biol., 8. 397 - 406.
38. PHIPPS, R.P., STEIN, S.H. & ROPER, R.L. (1991). A new view of prostaglandin E regulation of the immune response. Immunol. Today, 12, 349 - 352.
39. REXACH, M. & BLOBEL, G. (1995). Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell, 83, 683 - 692.
40. SEN, R. & BALTIMORE, D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46, 705 - 716.
41. SHIRAKAWA, F. & MITZEL, S.B. (1989). In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol., 9, 2424 - 2430.
42. SHULGA, N., ROBERTS, P., GU, Z., SPITZ, L., TABB, M.M., NOMURA, M. & GOLDFARB, D.S. (1996). In vivo nuclear transport kinetics in Saccharomyces cerevisiae: a role for heat shock protein 70 during targeting and translocation. J. Cell. Biol., 135, 329 - 339.
43. SIEBENLIST, U., FRANZOSO, G. & BROWN, K. (1994). Structure, regulation and function of NF-kappa B. Annu. Rev. Cell. Biol., 10, 405 - 455.
44. SUN, S.C., GANCHI, P.A., BERAUD, C. BALLARD, D.W. & GREENE, W.C. (1994). Autoregulation of the NF-kappa B transactivator ReIA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. U.S.A.. 91, 1346 - 1350.
45. TRAENCKNER, E.B., WILK, S. & BAEUERLE, P.A. (1994). A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. Embo J., 13, 5433 - 5441.
46. VANE, J. (1994). Towards a better aspirin. Nature, 367, 215 - 216.
47. VERMA, I.M., STEVENSON, J.K., SCHWARZ, E.M., VAN ANTWERP, D. & MIYAMOTO, S. (1995). Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev., 9, 2723 - 2735.
48. WEISSMANN, G. (1991). Aspirin. Sci. Am., 264, 84 - 90.
49. ZABEL, U., HENKEL, T., SILVA, M.S. & BAEUERLE, P.A. (1993). Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. Emho J., 12, 201 - 211.